Seon-Mi Yu

Seon-Mi Yu

Auto-generated profile, based on publicly available information

Seon-Mi Yu

Department of Biological Sciences, College of Natural Sciences Kongju National University Gongju Korea

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SYSeon-Mi Yu
Seon-Mi Yu
SKSong ja Kim
Song ja Kim
Yu SM, et al. J Korean Med Sci. 2014 Aug;29(8):1042-1053. https://doi.org/10.3346/jkms.2014.29.8.1042

8 April 2010
Verified
Journal Article
Closed access
SKSong-Ja Kim
Song-Ja Kim
SSSandesh A Sancheti
Sandesh A Sancheti
SSShruti S Sancheti
Shruti S Sancheti
BUByung-Hun Um
Byung-Hun Um
SYSeon-Mi Yu
Seon-Mi Yu
SSSung-Yum Seo
Sung-Yum Seo


31 July 2015 in International Journal of Oncology
Verified
Journal Article
Closed access
SYSeon-Mi Yu
Seon-Mi Yu
SKSong-Ja Kim
Song-Ja Kim
The cytosine analogue 5'-azacytidine (5'-aza) induces DNA hypomethylation by inhibiting DNA methyltransferase. In clinical trials, 5'-aza is widely used in epigenetic anticancer treatments. Accumulated evidence shows that cyclooxygenase-2 (COX-2) is overexpressed in various cancers, indicating that it may play a critical role in carcinogenesis. However, few studies have been performed to explore the molecular mechanism underlying the increased COX-2 expression. Therefore, we tested the hypothesis that 5'-aza regulates COX-2 expression and prostaglandin E2 (PGE2) production. The human fibrosarcoma cell line HT1080, was treated with various concentrations of 5'-aza for different time periods. Protein expressions of COX-2, DNA (cytosine-5)-methyltransferase 1 (DNMT1), pAkt, Akt, extracellular signal-regulated kinase (ERK), and phosphorylated ERK (pERK) were determined using western blot analysis, and COX-2 mRNA expression was determined using RT-PCR. PGE2 production was evaluated using the PGE2 assay kit. The localization and expression of COX-2 were determined using immunofluorescence staining. Treatment with 5'-aza induces protein and mRNA expression of COX-2. We also observed that 5'-aza-induced COX-2 expression and PGE2 production were inhibited by S-adenosylmethionine (SAM), a methyl donor. Treatment with 5'-aza phosphorylates PI3-kinase/Akt and ERK-1/2; inhibition of these pathways by LY294002, an inhibitor of PI3-kinase/Akt, or PD98059, an inhibitor of ERK-1/2, respectively, prevents 5'-aza-induced COX-2 expression and PGE2 production. Overall, these observations indicate that the hypomethylating agent 5'-aza modulates COX-2 expression via the PI3-kinase/Akt and ERK-1/2 pathways in human HT1080 fibrosarcoma cells.

1 January 2006 in Immune Network
Verified
Journal Article
Open access
PDF file
SYSeon-Mi Yu
Seon-Mi Yu
WLWon-Kil Lee
Won-Kil Lee
EYEun-Kyung Yoon
Eun-Kyung Yoon
JLJi-Hye Lee
Ji-Hye Lee
SLSun-Ryung Lee
Sun-Ryung Lee
SKSong ja Kim
Song ja Kim

30 April 2011 in Journal of Life Science
Verified
Journal Article
Closed access
SYSeon-Mi Yu
Seon-Mi Yu
SKSong-Ja Kim
Song-Ja Kim